Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Bhattacharya, Sudha
- Vaccine and Drug Trials in the COVID-19 Pandemic: Lessons For India
Abstract Views :234 |
PDF Views:83
Authors
Affiliations
1 Ashoka University, Sonepat 131 029, IN
2 Katoch is in the NASI-ICMR Chair on Public Health Research at Rajasthan University of Health Sciences, Jaipur 302 004, IN
1 Ashoka University, Sonepat 131 029, IN
2 Katoch is in the NASI-ICMR Chair on Public Health Research at Rajasthan University of Health Sciences, Jaipur 302 004, IN
Source
Current Science, Vol 119, No 2 (2020), Pagination: 171-172Abstract
The Coronavirus pandemic has caught most countries off guard, unprepared to handle a fast-spreading viral infection with a high rate of fatality and absence of any prophylactics and preventive agents. It has made it clear that a strong scientific base with access to novel technology platforms, trained scientific manpower and flexible regulatory systems are required to fight such infections and prevent future infections to go out of control. Developing the scientific and technology base could have a ripple effect in fighting several other incurable diseases, such as many forms of cancer and genetic disorders.Full Text
References
- Holmes, E., http://virological.org/t/initialgenome-release-of-novel-coronavirus/ 319
- https://www.statnews.com/2020/03/19/ an-updated-guide-to-the-coronavirusdrugsand-vaccines-in-development/
- https://www.fiercepharma.com/vaccines/ china-s-cansino-pushes-coronavirusvaccineinto-clinical-testing-as-modernadoses1st
- https://economictimes.indiatimes.com/news/ international/world-news/oxford-universitybegins-enrolling-over-500-volunteersforcoronavirus-vaccine-trial/articleshow/ 74864754.cms?from=mdr
- Saroja, Ch., Lakshmi, P. and Bhaskaran, S., Int. J. Pharm. Investig., 2011, 1, 64– 74.
- Dubensky Jr, T. W., Liu, M. A. and Ulmer, J. B., Mol. Med., 2000, 6, 723–732.
- https://www.who.int/blueprint/prioritydiseases/ key-action/novel-coronaviruslandscapencov.pdf?ua=1
- Richardson, J. S., Dekker, J. D., Croyle, M. A. and Kobinger, G. P., Hum. Vaccin., 2010, 6, 439–449.
- Acosta, P. L., Caballero, M. T. and Polack, F. P., Clin. Vaccine Immunol., 2015, 23, 189–195.
- Rauch, S., Jasny, E., Schmidt, K. E. and Petsch, B., Front Immunol., 2018, 9, 1963.
- Neuzil, K. M., Clin. Vaccine Immunol., 2016, 23, 186–188.
- Machicado, J. D., Bhagya-Rao, B., Davogustto, G. and McKelvy, B. J., Clin. Vaccine Immunol., 2013, 20, 1485–1486.
- Thor, S. W., Hilt, D. A., Kissinger, J. C., Paterson, A. H. and Jackwood, M. W., Viruses, 2011, 3, 1777–1799.
- Shi, M. et al., Nature, 2018, 556, 197– 202.
- https://deepmind.com/research/opensource/ computational-predictions-of-proteinstructures-associated-with-COVID-19 16. http://diosvax.com/covidresponse 17. Nair, N. P. et al., BMJ Open, 2019, 9, e024840.